Trials / Completed
CompletedNCT02846181
A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd. · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary objectives of the study are: * To assess the mass balance recovery after a single PO dose of \[14C\]-SK-1405 * To provide plasma, urine and faecal samples for metabolite profiling and structural identification
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]-SK-1405 |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2016-07-27
- Last updated
- 2016-11-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02846181. Inclusion in this directory is not an endorsement.